BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25168017)

  • 1. Increased chemokine excretion in patients suffering from chronic kidney disease.
    Lebherz-Eichinger D; Klaus DA; Reiter T; Hörl WH; Haas M; Ankersmit HJ; Krenn CG; Roth GA
    Transl Res; 2014 Dec; 164(6):433-43.e1-2. PubMed ID: 25168017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trefoil Factor 1 Excretion Is Increased in Early Stages of Chronic Kidney Disease.
    Lebherz-Eichinger D; Tudor B; Ankersmit HJ; Reiter T; Haas M; Roth-Walter F; Krenn CG; Roth GA
    PLoS One; 2015; 10(9):e0138312. PubMed ID: 26390128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased trefoil factor 2 levels in patients with chronic kidney disease.
    Lebherz-Eichinger D; Tudor B; Ankersmit HJ; Reiter T; Haas M; Einwallner E; Roth-Walter F; Krenn CG; Roth GA
    PLoS One; 2017; 12(3):e0174551. PubMed ID: 28355260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease.
    Lebherz-Eichinger D; Ankersmit HJ; Hacker S; Hetz H; Kimberger O; Schmidt EM; Reiter T; Hörl WH; Haas M; Krenn CG; Roth GA
    Clin Chim Acta; 2012 Jan; 413(1-2):282-6. PubMed ID: 22032827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal elimination of sclerostin increases with declining kidney function.
    Cejka D; Marculescu R; Kozakowski N; Plischke M; Reiter T; Gessl A; Haas M
    J Clin Endocrinol Metab; 2014 Jan; 99(1):248-55. PubMed ID: 24187403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of saliva urea, creatinine, and uric acid levels in patients with chronic kidney disease].
    Xia Y; Peng C; Zhou Z; Cheng P; Sun L; Peng Y; Xiao P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 37(11):1171-6. PubMed ID: 23202627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease.
    Viaene L; Meijers BK; Vanrenterghem Y; Evenepoel P
    Am J Nephrol; 2012; 35(5):434-41. PubMed ID: 22538635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
    Horii M; Matsumoto T; Uemura S; Sugawara Y; Takitsume A; Ueda T; Nakagawa H; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Takeda Y; Kawata H; Kawakami R; Saito Y
    J Cardiol; 2013 Jun; 61(6):410-6. PubMed ID: 23618914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease.
    Wan J; Wang Y; Cai G; Liang J; Yue C; Wang F; Song J; Wang J; Liu M; Luo J; Li L
    Oncotarget; 2016 Oct; 7(42):67748-67759. PubMed ID: 27589683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine and serum midkine levels in an Australian chronic kidney disease clinic population: an observational study.
    Campbell VK; Anstey CM; Gately RP; Comeau DC; Clark CJ; Noble EP; Mahadevan K; Hollett PR; Pollock AJ; Hall ST; Jones DR; Burg D; Gray NA
    BMJ Open; 2017 Sep; 7(9):e014615. PubMed ID: 28963279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the kidney failure risk equation in European CKD patients.
    Peeters MJ; van Zuilen AD; van den Brand JA; Bots ML; Blankestijn PJ; Wetzels JF;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1773-9. PubMed ID: 23645476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness.
    Yong K; Ooi EM; Dogra G; Mannion M; Boudville N; Chan D; Lim EM; Lim WH
    Cytokine; 2013 Oct; 64(1):39-42. PubMed ID: 23778029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progenitor cells and vascular function are impaired in patients with chronic kidney disease.
    Jie KE; Zaikova MA; Bergevoet MW; Westerweel PE; Rastmanesh M; Blankestijn PJ; Boer WH; Braam B; Verhaar MC
    Nephrol Dial Transplant; 2010 Jun; 25(6):1875-82. PubMed ID: 20083473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K; Masajtis-Zagajewska A; Nowicki M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.